FDA approves leucovorin for ultrarare cerebral folate deficiency subset without clinical trial
This story is reported by Fierce Pharma. Read what other outlets are saying below, then open the original report for full details.
This story is reported by Fierce Pharma. Read what other outlets are saying below, then open the original report for full details.